The company received more orders for BikeAround during the first half-year of 2018, than during 2017, driven by an increased demand among retirement communities in the US. It has become clear that there is a large interest from Swedish and Norwegian municipalities for the transition into digital care at home. The acquisition of Vital has an impact on sales during 2018, however, the large upside is expected in the coming years. In order to grow with the global market demand, growth capital is needed. Therefore, Camanio is now making the following strategic decisions:

• The company has decided to apply for a full listing on Nasdaq First North. The transfer of stock exchange is planned in order to facilitate the increasing demand from international stakeholders, such as institutions, users and their relatives, to become shareholders in Camanio Care.

• Camanio Care prepares for an investor road-show in selected local markets to inform shareholders about the expansion and plans a smaller fully underwritten rights issue. The terms and timing will be determined within the coming weeks.

For further information, please contact:

Catharina Borgenstierna, CEO
Telephone: +46733-93 00 07
E-mail: catharina.borgenstierna@camanio.com

About Camanio Care

Camanio Care is a care tech company that develops smart technologies for an excellent care at home with the individual in focus. Camanio Care offers digital service platforms for digital care, robotics and assistive devices, with products such as VITAL, BikeAround TM, Bestic® and Giraff TM. Through three focus areas; Activation, Mealtime and Digital care, Camanio Care wishes to support people"s basic needs and increase accessibility and quality within health care. Camanio Care AB has its headquarters in Stockholm, a US subsidiary, Camanio Care Inc., as well as distributors in Asia, the Middle East, Hong Kong, Australia and in ten European countries.

Subscribe to our press releases and/or read more about us, Camanio Care at: www.camanio.com.

This information is information that Camanio Care is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, on September 26th, 2018.